Skip to main content
锦好医疗 logo

锦好医疗 — Investor Relations & Filings

Ticker · 920925 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 568 across all filing types
Latest filing 2022-11-01 Share Issue/Capital Cha…
Country CN China
Listing Beijing Stock Exchange 920925

About 锦好医疗

https://www.jinghao.cn/

Jinghao Medical specializes in the research, development, and manufacturing of hearing aids and home medical electronic products. The company's core portfolio includes digital and analog hearing aids, medical nebulizers, and electronic blood pressure monitors. It focuses on providing hearing health solutions by integrating advanced digital signal processing technology into its devices. Jinghao Medical operates extensively in the global market, offering original design manufacturing (ODM) and original equipment manufacturing (OEM) services to international partners. The organization emphasizes technological innovation and maintains rigorous quality management systems to comply with international medical device standards. Its primary objective is to deliver accessible, high-performance medical equipment designed to improve the quality of life for users with hearing loss and other chronic health conditions.

Recent filings

Filing Released Lang Actions
股票解除限售公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the lifting of stock trading restrictions (解除限售公告) for certain shares of the company. It details the number of shares becoming tradable, the shareholders involved, and the reasons for lifting the restrictions. There is no financial data, earnings information, or management discussion. The document is a regulatory announcement about share status changes rather than a financial report or management disclosure. It fits best under the category of Share Issue/Capital Change (SHA) because it concerns changes in share tradability and capital structure.
2022-11-01 Chinese
关于召开2022年第五次临时股东大会通知公告（提供网络投票）
Regulatory Filings Classification · 95% confidence The document is a notice announcing the convening of the 2022 fifth extraordinary general meeting of shareholders (临时股东大会) of Huizhou Jin Hao Medical Technology Co., Ltd. It details the meeting date, voting methods (including online voting), agenda items for shareholder approval, registration methods, and other procedural information. There is no financial data, earnings, or report content included. The document is a formal announcement of a shareholder meeting rather than the meeting materials or results themselves. It is also not a proxy solicitation or voting results announcement. Given the content and length (2619 characters), it fits the category of a regulatory announcement about a shareholder meeting, which aligns best with Regulatory Filings (RNS) as a fallback category for such notices that do not fit other specific categories.
2022-10-27 Chinese
关于使用部分闲置募集资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Huizhou Jin Hao Medical Technology Co., Ltd. regarding the use of part of idle raised funds for cash management. It details the background of the fundraising, the usage and storage of the raised funds, the decision-making process including board and supervisory committee approvals, independent director opinions, and the impact on the company. The document is a formal disclosure about the company's financing activities related to the management of raised capital, specifically the use of idle funds for investment in safe financial products. It is not a full financial report, audit, or earnings release, nor is it a meeting presentation or voting result. It fits the category of a Capital/Financing Update as it provides an update on the company's fundraising capital usage and management. The document length is 3332 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2022-10-27 Chinese
2022年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2022 Third Quarter Report" of 惠州市锦好医疗科技股份有限公司 (Huizhou Jin Hao Medical Technology Co., Ltd.). It contains detailed financial data for the period from July 1, 2022 to September 30, 2022, including balance sheet, income statement, cash flow statement, and explanations of significant changes in financial data. It also includes information about shareholders, major events, and management assurances about the report's accuracy. The document explicitly states it is a quarterly report and is unaudited. The length is about 15,000 characters, indicating a full report rather than a brief announcement. This matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial statements and substantive analysis. Therefore, the document should be classified as IR. Q3 2022
2022-10-27 Chinese
独立董事关于第二届董事会第二十一次会议有关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from independent directors regarding specific proposals discussed at a board meeting, specifically about the use of idle raised funds and idle own funds for cash management and purchasing financial products. It references the board meeting date and the proposals to be submitted to the shareholders' meeting. The document is short (768 characters) and does not contain financial statements or detailed financial data. It is not a full report but an opinion related to board matters and proposals for shareholder approval. This fits best under Board/Management Information (MANG) as it relates to board meeting opinions and decisions, rather than a full financial report or announcement of voting results.
2022-10-27 Chinese
第二届董事会第二十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 21st meeting of the 2nd Board of Directors of Huizhou Jin Hao Medical Technology Co., Ltd. It details the meeting date, attendance, agenda items, voting results, and mentions that some proposals will be submitted to the shareholders' meeting. The content focuses on board meeting decisions rather than full financial reports or other filings. It is not a full annual or quarterly report, nor an earnings release or audit report. It is not a proxy statement or voting results announcement for shareholders but a board meeting resolution announcement. Therefore, the document fits best under Board/Management Information (MANG). The document length is short and does not contain detailed financial data or presentations, so it is not an investor presentation or interim report. Confidence is high due to clear meeting and resolution content.
2022-10-27 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.